BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

917 related articles for article (PubMed ID: 29311743)

  • 1. TDP-43 pathology disrupts nuclear pore complexes and nucleocytoplasmic transport in ALS/FTD.
    Chou CC; Zhang Y; Umoh ME; Vaughan SW; Lorenzini I; Liu F; Sayegh M; Donlin-Asp PG; Chen YH; Duong DM; Seyfried NT; Powers MA; Kukar T; Hales CM; Gearing M; Cairns NJ; Boylan KB; Dickson DW; Rademakers R; Zhang YJ; Petrucelli L; Sattler R; Zarnescu DC; Glass JD; Rossoll W
    Nat Neurosci; 2018 Feb; 21(2):228-239. PubMed ID: 29311743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear transport dysfunction: a common theme in amyotrophic lateral sclerosis and frontotemporal dementia.
    Jovičić A; Paul JW; Gitler AD
    J Neurochem; 2016 Aug; 138 Suppl 1():134-44. PubMed ID: 27087014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Traffic jam at the nuclear pore: All roads lead to nucleocytoplasmic transport defects in ALS/FTD.
    Fallini C; Khalil B; Smith CL; Rossoll W
    Neurobiol Dis; 2020 Jul; 140():104835. PubMed ID: 32179176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. G
    Coyne AN; Zaepfel BL; Hayes L; Fitchman B; Salzberg Y; Luo EC; Bowen K; Trost H; Aigner S; Rigo F; Yeo GW; Harel A; Svendsen CN; Sareen D; Rothstein JD
    Neuron; 2020 Sep; 107(6):1124-1140.e11. PubMed ID: 32673563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-to-cell transmission of C9orf72 poly-(Gly-Ala) triggers key features of ALS/FTD.
    Khosravi B; LaClair KD; Riemenschneider H; Zhou Q; Frottin F; Mareljic N; Czuppa M; Farny D; Hartmann H; Michaelsen M; Arzberger T; Hartl FU; Hipp MS; Edbauer D
    EMBO J; 2020 Apr; 39(8):e102811. PubMed ID: 32175624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The C9orf72 repeat expansion disrupts nucleocytoplasmic transport.
    Zhang K; Donnelly CJ; Haeusler AR; Grima JC; Machamer JB; Steinwald P; Daley EL; Miller SJ; Cunningham KM; Vidensky S; Gupta S; Thomas MA; Hong I; Chiu SL; Huganir RL; Ostrow LW; Matunis MJ; Wang J; Sattler R; Lloyd TE; Rothstein JD
    Nature; 2015 Sep; 525(7567):56-61. PubMed ID: 26308891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Traumatic injury compromises nucleocytoplasmic transport and leads to TDP-43 pathology.
    Anderson EN; Morera AA; Kour S; Cherry JD; Ramesh N; Gleixner A; Schwartz JC; Ebmeier C; Old W; Donnelly CJ; Cheng JP; Kline AE; Kofler J; Stein TD; Pandey UB
    Elife; 2021 May; 10():. PubMed ID: 34060470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear import receptors are recruited by FG-nucleoporins to rescue hallmarks of TDP-43 proteinopathy.
    Khalil B; Chhangani D; Wren MC; Smith CL; Lee JH; Li X; Puttinger C; Tsai CW; Fortin G; Morderer D; Gao J; Liu F; Lim CK; Chen J; Chou CC; Croft CL; Gleixner AM; Donnelly CJ; Golde TE; Petrucelli L; Oskarsson B; Dickson DW; Zhang K; Shorter J; Yoshimura SH; Barmada SJ; Rincon-Limas DE; Rossoll W
    Mol Neurodegener; 2022 Dec; 17(1):80. PubMed ID: 36482422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LSM12-EPAC1 defines a neuroprotective pathway that sustains the nucleocytoplasmic RAN gradient.
    Lee J; Park J; Kim JH; Lee G; Park TE; Yoon KJ; Kim YK; Lim C
    PLoS Biol; 2020 Dec; 18(12):e3001002. PubMed ID: 33362237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stress Granule Assembly Disrupts Nucleocytoplasmic Transport.
    Zhang K; Daigle JG; Cunningham KM; Coyne AN; Ruan K; Grima JC; Bowen KE; Wadhwa H; Yang P; Rigo F; Taylor JP; Gitler AD; Rothstein JD; Lloyd TE
    Cell; 2018 May; 173(4):958-971.e17. PubMed ID: 29628143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nucleocytoplasmic Proteomic Analysis Uncovers eRF1 and Nonsense-Mediated Decay as Modifiers of ALS/FTD C9orf72 Toxicity.
    Ortega JA; Daley EL; Kour S; Samani M; Tellez L; Smith HS; Hall EA; Esengul YT; Tsai YH; Gendron TF; Donnelly CJ; Siddique T; Savas JN; Pandey UB; Kiskinis E
    Neuron; 2020 Apr; 106(1):90-107.e13. PubMed ID: 32059759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear accumulation of CHMP7 initiates nuclear pore complex injury and subsequent TDP-43 dysfunction in sporadic and familial ALS.
    Coyne AN; Baskerville V; Zaepfel BL; Dickson DW; Rigo F; Bennett F; Lusk CP; Rothstein JD
    Sci Transl Med; 2021 Jul; 13(604):. PubMed ID: 34321318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A feedback loop between dipeptide-repeat protein, TDP-43 and karyopherin-α mediates C9orf72-related neurodegeneration.
    Solomon DA; Stepto A; Au WH; Adachi Y; Diaper DC; Hall R; Rekhi A; Boudi A; Tziortzouda P; Lee YB; Smith B; Bridi JC; Spinelli G; Dearlove J; Humphrey DM; Gallo JM; Troakes C; Fanto M; Soller M; Rogelj B; Parsons RB; Shaw CE; Hortobágyi T; Hirth F
    Brain; 2018 Oct; 141(10):2908-2924. PubMed ID: 30239641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A proteomic network approach across the ALS-FTD disease spectrum resolves clinical phenotypes and genetic vulnerability in human brain.
    Umoh ME; Dammer EB; Dai J; Duong DM; Lah JJ; Levey AI; Gearing M; Glass JD; Seyfried NT
    EMBO Mol Med; 2018 Jan; 10(1):48-62. PubMed ID: 29191947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LINC complex alterations are a key feature of sporadic and familial ALS/FTD.
    Sirtori R; J Gregoire M; M Potts E; Collins A; Donatelli L; Fallini C
    Acta Neuropathol Commun; 2024 Apr; 12(1):69. PubMed ID: 38664831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cryptic exon detection and transcriptomic changes revealed in single-nuclei RNA sequencing of C9ORF72 patients spanning the ALS-FTD spectrum.
    Gittings LM; Alsop EB; Antone J; Singer M; Whitsett TG; Sattler R; Van Keuren-Jensen K
    Acta Neuropathol; 2023 Sep; 146(3):433-450. PubMed ID: 37466726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stable transgenic C9orf72 zebrafish model key aspects of the ALS/FTD phenotype and reveal novel pathological features.
    Shaw MP; Higginbottom A; McGown A; Castelli LM; James E; Hautbergue GM; Shaw PJ; Ramesh TM
    Acta Neuropathol Commun; 2018 Nov; 6(1):125. PubMed ID: 30454072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear-import receptors as gatekeepers of pathological phase transitions in ALS/FTD.
    Khalil B; Linsenmeier M; Smith CL; Shorter J; Rossoll W
    Mol Neurodegener; 2024 Jan; 19(1):8. PubMed ID: 38254150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NEUROSCIENCE. Plugged pores may underlie some ALS, dementia cases.
    Underwood E
    Science; 2015 Aug; 349(6251):911-2. PubMed ID: 26315413
    [No Abstract]   [Full Text] [Related]  

  • 20. Sigma-1 receptor chaperones rescue nucleocytoplasmic transport deficit seen in cellular and Drosophila ALS/FTD models.
    Lee PT; Liévens JC; Wang SM; Chuang JY; Khalil B; Wu HE; Chang WC; Maurice T; Su TP
    Nat Commun; 2020 Nov; 11(1):5580. PubMed ID: 33149115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.